
Sino Biological/HIV-1 gp120 Protein (group M, subtype CRF07_BC) (His Tag)/1/11233-V08H
商品编号:
11233-V08H
品牌:
sinobiological
市场价:
¥0.00
美元价:
0.00
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
HIV-1 gp120 Protein (group M, subtype CRF07_BC) (His Tag): Product Information
Purity
> 95 % as determined by SDS-PAGE
Endotoxin
< 1.0="" eu="" per="" μg="" of="" the="" protein="" as="" determined="" by="" the="" lal="">
Activity
Testing in progress
Protein Construction
A DNA sequence encoding the HIV-1 envelope glycoprotein gp120 (AFM77980.1) (Ala29-Glu502) was fused with a polyhistidine tag at the C-terminus.
Accession#
AFM77980.1
Expressed Host
HEK293 Cells
Species
HIV
Predicted N Terminal
Ala 29
Molecule Mass
The recombinant HIV-1 gp120 consists of 485 amino acids after removal of the signal peptide and has a predicted molecular mass of 54.8 kDa. The apparent molecular mass of the recombinant protein is approximately 70-120 kDa in SDS-PAGE under reducing conditions.
Formulation
Lyophilized from sterile PBS, pH 7.4Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
Shipping
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Stability & Storage
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.
HIV-1 gp120 Protein (group M, subtype CRF07_BC) (His Tag): Images

HIV gp120 Background Information
The HIV-1 gp120 envelope protein, a glycoprotein that is part of the outer layer of the virus, is an essential component in the multi-tiered viral entry process. It presents itself as viral membrane spikes consisting of 3 molecules of gp120 linked together and anchored to the membrane by gp41 protein. Gp120 is essential for viral infection as it facilitates HIV entry into the host cell and this is its best-known and most researched role in HIV infection. However, it is becoming increasingly evident that gp120 might also be facilitating viral persistence and continuing HIV infection by influencing the T cell immune response to the virus. The surface protein gp120 attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. Gp120 binding to its receptor CD4 and co-receptor, CXCR4 or CCR5 is required for fusion of viral and cellular membranes. Several mechanisms might be involved in this process of which gp120 binding to the CD4 receptor of T cells is the best known and most important interaction as it facilitates viral entry into the CD4+ cells and their depletion, a hallmark of the HIV infection. Gp120 is shed from the viral membrane and accumulates in lymphoid tissues in significant amounts. Despite the overall genetic heterogeneity of the gp120 glycoprotein, the conserved CD4 binding site provides an attractive antiviral target. Interaction between gp120 and ITGA4/ITGB7 would allow the virus to enter GALT early in the infection, infecting and killing most of GALT"s resting CD4+ T-cells. This T-cell depletion is believed to be the major insult to the host immune system leading to AIDS.
References
- Kadow J, et al. (2006) Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development. Curr Opin Investig Drugs. 7(8): 721-6.
- Stevceva L, et al. (2007) Immune responses to HIV Gp120 that facilitate viral escape. Curr HIV Res. 5(1): 47-54.
- Yoon V, et al. (2010) The GP120 molecule of HIV-1 and its interaction with T cells. Curr Med Chem. 17(8): 741-9.
HIV HIV gp120 Proteins
- HIV-1 gp120 Protein (group P, strain RBF168) (His Tag)40259-V08H1
- HIV-1 (group M, subtype A, isolate 92RW020) Envelope glycoprotein gp160 Protein (gp120 subunit) (His Tag)40403-V08H
- HIV-1 (group M, subtype B, isolate BAL) gp120 Protein (His Tag)40404-V08H
- HIV-1 gp160 Protein (gp120 subunit) (group N, strain 06CM-U14296) (His Tag)40255-V08H
- Human immunodeficiency virus 1 (HIV-1) (group M, subtype B, Isolate MN) gp120 Protein (His Tag)40405-V08H
- HIV-1 (group M, subtype B, strain SHIV-89.6P) gp120 Protein (His Tag)40402-V08H
- Glycan analysis by isobaric aldehyde reactive tags and mass spectrometryAuthorYang S, Yuan W, Yang W, Zhou J, Harlan R, Edwards J, Li S, Zhang H.Year2013JournalAnal. Chem.ApplicationN-Glycans IsolationPubMed ID: 23895018FoldedExpand
- Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptorAuthorTomašić, T;Hajšek, D;Švajger, U;Luzar, J;Obermajer, N;Petit-Haertlein, I;Fieschi, F;Anderluh, M;Year2014JournalEur J Med ChemApplicationCompetitive gp120-displacement assayPubMed ID: 24556146FoldedExpand
- Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque ModelAuthorZhao, C;Gunawardana, M;Villinger, F;Baum, MM;Remedios-Chan, M;Moench, TR;Zeitlin, L;Whaley, KJ;Bohorov, O;Smith, TJ;Anderson, DJ;Moss, JA;Year2017JournalAntimicrob. Agents Chemother.ApplicationELISA(as coating antigen)PubMed ID: 28416548FoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
E.coli protein expression service
Mammalian transient protein expression service
Baculovirus-insect expression service
Stable cell line development service (CHO / HEK293)
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。
联络我们